[
  {
    "info": {
      "NCT": "NCT03940703",
      "jit": "Tempus",
      "trial_name": "EMDs"
    },
    "disease": {
      "summary": " Non-small Cell Lung Cancer",
      "details": [
        {
          "code": "Non-Small Cell Lung Cancer (NSCLC)",
          "selection": "include"
        }
      ]
    },
    "query": {
      "nct": "NCT03940703",
      "title": "A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)",
      "current_status": "Recruiting",
      "status_verif_date": "July 2022",
      "last_update_date": "August 3, 2022",
      "trial_hold_status": "open",
      "sponsor": "EMD Serono Research & Development Institute, Inc.",
      "brief_summary": "This study will assess the antitumor activity, safety, tolerability, and pharmacokinetics (PK) of the Mesenchymal-epithelial Transition Factor (MET) inhibitor tepotinib combined with the 3rd generation EGFR inhibitor osimertinib in participants with advanced or metastatic non-small cell lung cancer (NSCLC).",
      "conditions": "Non-small Cell Lung Cancer",
      "type": "Interventional",
      "phase": "Phase 2",
      "arm": [
        {
          "ArmID": "1",
          "cohortlabel": "Tepotinib and Osimertinib",
          "drug": "Tepotinib | Osimertinib",
          "arm_type": "Experimental",
          "line_of_therapy": "Not available",
          "arm_hold_status": "open",
          "biomarker": [
            {
              "cohort": "Tepotinib and Osimertinib",
              "Gene": "MET",
              "Gene2": "Not available",
              "Type": "Amplification",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Not available",
              "summary": "MET Amplification  "
            }
          ]
        },
        {
          "ArmID": "2",
          "cohortlabel": "Tepotinib Mono-therapy",
          "drug": "Tepotinib | NA",
          "arm_type": "Experimental",
          "line_of_therapy": "Not available",
          "arm_hold_status": "open",
          "biomarker": [
            {
              "cohort": "Tepotinib Mono-therapy",
              "Gene": "MET",
              "Gene2": "Not available",
              "Type": "Amplification",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Not available",
              "summary": "MET Amplification  "
            }
          ]
        }
      ],
      "docs": "SDSADFSAF",
      "min_age": "18 Years",
      "gender": "All",
      "link": "<a href=\"https://clinicaltrials.gov/ct2/show/NCT03940703\" target=\"_blank\">NCT03940703<\/a>"
    }
  }
]
